Evidence map›Paper›PMID 23495885›Full record

ArticleJournal of proteome research2013

Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis.

Paul D Piehowski, Vladislav A Petyuk, Daniel J Orton, Fang Xie, Ronald J Moore, Manuel Ramirez-Restrepo, Anzhelika Engel, Andrew P Lieberman, Roger L Albin, David G Camp and 2 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Brain Proteomic Responses to Glucocorticoids and Their Relationship With Transcriptome: A Systematic Meta-Analysis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Pooled it
  2. Pooled it
  3. Protein Variability Patterns in Ovarian Serous Carcinoma.International journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. To Impute or Not To Impute in Untargeted Metabolomics─That is the Compositional Question.Journal of the American Society for Mass Spectrometry · 2025
    Article
  17. Article
  18. Article
  19. UrinaryJournal of cellular immunology · 2025
    Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paul D PiehowskiBiological Sciences Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, USA.
Vladislav A Petyuk
Daniel J Orton
Fang Xie
Ronald J Moore
Manuel Ramirez-Restrepo
Anzhelika Engel
Andrew P Lieberman
Roger L Albin
David G Camp
Richard D Smith
Amanda J Myers

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
TELEPHONE COUNSELING INTERVENTION TO PROMOTE CAREGIVER SELF CARE BEHAVIORP50AG008671 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GILMAN, SID · 1989 to 2010
$18.9M
THE HUMAN BRAINOME:genome, transcriptome and proteome interaction in human cortexR01AG034504 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MYERS, AMANDA J · 2009 to 2012
$1.1M
SURFACE CHEMISTRY OF MYCOBACTERIAR01AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1989 to 1989
–
SURFACE CHEMISTRY OF MYCOBACTERIAR22AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1985 to 1989
–
NCRR NIH HHS 5 P41 RR018522-10NCRR NIH HHS P41 RR018522NIAID NIH HHS Y01 AI008401NIAID NIH HHS Y1-AI-8401NIA NIH HHS P50 AG008671NIA NIH HHS P50-AG08671NIA NIH HHS R01 AG034504NIA NIH HHS R01-AG-034504NIGMS NIH HHS 8 P41 GM103493-10NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

To design a robust quantitative proteomics study, an understanding of both the inherent heterogeneity of the biological samples being studied as well as the technical variability of the proteomics methods and platform is needed. Additionally, accurately identifying the technical steps associated with the largest variability would provide valuable information for the improvement and design of future processing pipelines. We present an experimental strategy that allows for a detailed examination of the variability of the quantitative LC-MS proteomics measurements. By replicating analyses at different stages of processing, various technical components can be estimated and their individual contribution to technical variability can be dissected. This design can be easily adapted to other quantitative proteomics pipelines. Herein, we applied this methodology to our label-free workflow for the processing of human brain tissue. For this application, the pipeline was divided into four critical components: Tissue dissection and homogenization (extraction), protein denaturation followed by trypsin digestion and SPE cleanup (digestion), short-term run-to-run instrumental response fluctuation (instrumental variance), and long-term drift of the quantitative response of the LC-MS/MS platform over the 2 week period of continuous analysis (instrumental stability). From this analysis, we found the following contributions to variability: extraction (72%) >> instrumental variance (16%) > instrumental stability (8.4%) > digestion (3.1%). Furthermore, the stability of the platform and its suitability for discovery proteomics studies is demonstrated.

Indexed as

AgedAlgorithmsAlzheimer DiseaseArtifactsBrainCase-Control StudiesHumansMaleModels, BiologicalNerve Tissue ProteinsProteomeProteomicsReference StandardsReproducibility of ResultsSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryNerve Tissue ProteinsProteome

Identifiers

PMID23495885
PMCPMC3695475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.